Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Aflac Incorporated
Aflac Incorporated News
Aflac Incorporated Quantitative Score
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Aflac Incorporated Earnings & Revenue
Aflac Incorporated Financials
Table Compare
Compare AFL metrics with: | |||
|---|---|---|---|
Earnings & Growth | AFL | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | AFL | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | AFL | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | AFL | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Aflac Incorporated Income
Aflac Incorporated Balance Sheet
Aflac Incorporated Cash Flow
Aflac Incorporated Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Aflac Incorporated Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.1600 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-06-02 | 0.58 | Quarterly |
| 2025-03-03 | 0.58 | Quarterly |
| 2024-12-02 | 0.5 | Quarterly |
| 2024-09-02 | 0.5 | Quarterly |
| 2024-06-03 | 0.5 | Quarterly |
Aflac Incorporated Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Aflac Incorporated Executives
| Name | Role |
|---|---|
| Mr. Daniel Paul Amos | Chairman & Chief Executive Officer |
| Mr. Max Kristian Broden C.F.A. | Senior EVice President & Chief Financial Officer |
| Mr. Bradley Eugene Dyslin C.F.A. | Executive Vice President, Global Chief Investment Officer & President of Aflac Global Investments |
| Ms. Audrey Boone Tillman Esq. | Senior EVice President, & General Counsel |
| Mr. Virgil Raynard Miller | President |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Daniel Paul Amos | Chairman & Chief Executive Officer | Male | 1952 | 8.87M |
| Mr. Max Kristian Broden C.F.A. | Senior EVice President & Chief Financial Officer | Male | 1979 | 3.7M |
| Mr. Bradley Eugene Dyslin C.F.A. | Executive Vice President, Global Chief Investment Officer & President of Aflac Global Investments | Male | 1966 | 3.63M |
| Ms. Audrey Boone Tillman Esq. | Senior EVice President, & General Counsel | Female | 1965 | 2.33M |
| Mr. Virgil Raynard Miller | President | Male | 1969 | 2.06M |
Aflac Incorporated Insider Trades
| Date | 15 May |
| Name | Collins Arthur Reginald |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 2750 |
| Date | 9 May |
| Name | KENNY THOMAS J |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 7168 |
| Date | 8 May |
| Name | MOSKOWITZ JOSEPH L |
| Role | Director |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 1000 |
| Date | 5 May |
| Name | Rohrer Katherine |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 1703 |
| Date | 5 May |
| Name | Collins Arthur Reginald |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 1703 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 15 May | Collins Arthur Reginald | Director | Disposed | S-Sale | 2750 |
| 9 May | KENNY THOMAS J | Director | Disposed | S-Sale | 7168 |
| 8 May | MOSKOWITZ JOSEPH L | Director | Disposed | S-Sale | 1000 |
| 5 May | Rohrer Katherine | Director | Acquired | A-Award | 1703 |
| 5 May | Collins Arthur Reginald | Director | Acquired | A-Award | 1703 |